Insider Buying: Vitamin Shoppe Insider Acquires 5,000 Shares of Stock (VSI)
Vitamin Shoppe (NYSE:VSI) Insider Anthony Alfonso bought 5,000 shares of Vitamin Shoppe stock in a transaction dated Wednesday, June 11th. The shares were purchased at an average price of $44.44 per share, with a total value of $222,200.00. Following the transaction, the insider now directly owns 5,000 shares of the company’s stock, valued at approximately $222,200. The acquisition was disclosed in a filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Bank of America upgraded shares of Vitamin Shoppe from an “underperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $47.00 price target on the stock. Separately, analysts at Barclays upgraded shares of Vitamin Shoppe from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 9th. They now have a $51.00 price target on the stock, up previously from $49.00. Finally, analysts at Jefferies Group raised their price target on shares of Vitamin Shoppe from $45.00 to $48.00 in a research note on Friday, May 9th. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $52.72.
Shares of Vitamin Shoppe (NYSE:VSI) traded up 0.02% on Friday, hitting $44.40. 237,901 shares of the company’s stock traded hands. Vitamin Shoppe has a 52-week low of $39.92 and a 52-week high of $55.20. The stock has a 50-day moving average of $44.18 and a 200-day moving average of $46.79. The company has a market cap of $1.345 billion and a price-to-earnings ratio of 20.45.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.67 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.68 by $0.01. The company had revenue of $307.80 million for the quarter, compared to the consensus estimate of $302.82 million. During the same quarter in the prior year, the company posted $0.72 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. Analysts expect that Vitamin Shoppe will post $2.42 EPS for the current fiscal year.
Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.